newsfilter
← Latest News
GlobeNewswire·

Calithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced its financial results for the fourth quarter and year ended Decem